Musculoskeletal Disorders
Latest News
First referral guide issued for axial spondyloarthritis
The draft recommendations are a “good first step,” but more awareness around axial spondyloarthritis in the nonrheumatology community is also...
PURLs
A new standard for treatment of torus fractures of the wrist?
A large multicenter trial evaluated effects on pain and function for pediatric patients treated with a soft bandage vs rigid immobilization.
Latest News
Strength training promotes knee health, lowers OA risk
The association between strength training and less frequent knee pain, less radiographic OA, and less symptomatic OA was strongest in the older...
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News from the FDA/CDC
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...
Sponsored Supplement
Osteoarthritis as a Chronic Disease: Maximizing Management in Primary Care
News from the FDA/CDC
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
Commentary
Should people who play sports pay higher medical insurance premiums?
I don’t like a society where anybody who tries to do something that takes risk winds up bearing extra cost for doing that.
Latest News
Treating fractures in elderly patients: Beyond the broken bone
Osteoporosis management can prevent fractures, and follow-up after fractures can prevent future breaks.
Applied Evidence
Knee pain and injury: When is a surgical consult needed?
This review identifies clinical scenarios—such as unstable or displaced fractures, major tendon ruptures, and significant mechanical issues—that...
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
Latest News
All in stride: Few age limitations for joint replacement
Primary care physicians should ask patients if the pain affects their day-to-day lives and if they were unresponsive to nonsurgical treatments...